476 related articles for article (PubMed ID: 18005013)
1. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
[TBL] [Abstract][Full Text] [Related]
2. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
[TBL] [Abstract][Full Text] [Related]
3. Hepatic encephalopathy due to TIPS--retrospective study.
Stefánková J; Hůleki P; Babu A; Cermáková E; Safka V; Stefanek J; Fejfar T; Krajina A
Hepatogastroenterology; 2007 Mar; 54(74):480-4. PubMed ID: 17523303
[TBL] [Abstract][Full Text] [Related]
4. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute of Medical Sciences Islamabad.
Maqsood S; Saleem A; Iqbal A; Butt JA
J Ayub Med Coll Abbottabad; 2006; 18(4):58-62. PubMed ID: 17591012
[TBL] [Abstract][Full Text] [Related]
5. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
Moriwaki H; Shiraki M; Iwasa J; Terakura Y
J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
[TBL] [Abstract][Full Text] [Related]
6. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
[TBL] [Abstract][Full Text] [Related]
7. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J
Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
[TBL] [Abstract][Full Text] [Related]
9. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
10. Protein energy malnutrition predicts complications in liver cirrhosis.
Huisman EJ; Trip EJ; Siersema PD; van Hoek B; van Erpecum KJ
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):982-9. PubMed ID: 21971339
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.
Sigal SH; Stanca CM; Kontorinis N; Bodian C; Ryan E
Am J Gastroenterol; 2006 Jul; 101(7):1490-6. PubMed ID: 16863551
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
[TBL] [Abstract][Full Text] [Related]
13. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
[TBL] [Abstract][Full Text] [Related]
14. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
Ndraha S; Hasan I; Simadibrata M
Acta Med Indones; 2011 Jan; 43(1):18-22. PubMed ID: 21339541
[TBL] [Abstract][Full Text] [Related]
15. [An epidemiological survey of subclinical hepatic encephalopathy].
Zeng Z; Li YY; Nie YQ
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):680-2. PubMed ID: 14636446
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
[TBL] [Abstract][Full Text] [Related]
17. [Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].
Mesejo A; Juan M; Serrano A
Nutr Hosp; 2008 May; 23 Suppl 2():8-18. PubMed ID: 18714406
[TBL] [Abstract][Full Text] [Related]
18. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
19. Impact of liver cirrhosis on nutritional and immunological status.
Sobhonslidsuk A; Roongpisuthipong C; Nantiruj K; Kulapongse S; Songchitsomboon S; Sumalnop K; Bussagorn N
J Med Assoc Thai; 2001 Jul; 84(7):982-8. PubMed ID: 11759979
[TBL] [Abstract][Full Text] [Related]
20. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
Cadranel JF; Lebiez E; Di Martino V; Bernard B; El Koury S; Tourbah A; Pidoux B; Valla D; Opolon P
Am J Gastroenterol; 2001 Feb; 96(2):515-8. PubMed ID: 11232699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
